GS MedTech Funding Tracker – Nyxoah, Wise, and more

GS Funding Tracker
A strong signal of execution across the sector this week, with MedTech companies raising capital to accelerate commercialization, expand clinical adoption, and strengthen U.S. market presence. Nyxoah secures $110M financing to accelerate U.S. launch of...

GS MedTech Funding Tracker – Nyxoah, Wise, and more

GS Funding Tracker
A strong signal of execution across the sector this week, with MedTech companies raising capital to accelerate commercialization, expand clinical adoption, and strengthen U.S....

AngioDynamics wins FDA IDE for feasibility study of NanoKnife in BPH

Regulatory Approvals
AngioDynamics has received FDA investigational device exemption (IDE) approval to begin the RELIEF feasibility study, evaluating its NanoKnife system for treating lower urinary tract...

Sonire Therapeutics awarded $13M from Japanese government-backed innovation agency

Funding
Sonire Therapeutics has been awarded a $13 million grant from Japan’s New Energy and Industrial Technology Development Organization (NEDO) to accelerate development of its...

Icarus Medical secures $7.2M Series A to accelerate growth and innovation

Funding
Icarus Medical has secured an oversubscribed $7.2 million Series A financing round to accelerate commercialization and development of its orthopedic bracing technologies. The Charlottesville-based medtech...

Get Weekly Newsletter

[hubspot type=form portal=25601863 id=e07d0241-001f-4840-8c08-6e5a4f7af710]

Finance

Funding

Clinical Trials

Raydiant Oximetry completes enrollment of First 15 Patients in IDE Pilot Study

Raydiant Oximetry has completed enrollment and data collection for the first 15 patients in its FDA-approved IDE pilot study at LSU Health Shreveport, advancing...

Airiver treats first patient in drug-coated balloon study for chronic rhinosinusitis

Airiver Medical has announced the first patient treatment in its RESTORE-2 pivotal clinical trial evaluating its ESSpand drug-coated balloon (DCB) for chronic rhinosinusitis (CRS). The...

Anteris to expand global heart valve trial

Anteris Technologies announced that it received full regulatory clearance to expand its PARADIGM trial to France. The company - founded in Brisbane, Australia with a...

Neuronoff implants first patient in DOD-funded trial of Injectrode

Neuronoff, a clinical-stage neuromodulation company, announced the first patient implant in a Department of Defense (DOD) funded clinical trial evaluating the safety and efficacy...

Innovation

Regulatory Approvals

GS MedTech Funding Tracker – Nyxoah, Wise, and more

A strong signal of execution across the sector this week, with MedTech companies raising capital to accelerate commercialization, expand clinical adoption, and strengthen U.S....

AngioDynamics wins FDA IDE for feasibility study of NanoKnife in BPH

AngioDynamics has received FDA investigational device exemption (IDE) approval to begin the RELIEF feasibility study, evaluating its NanoKnife system for treating lower urinary tract...

Sonire Therapeutics awarded $13M from Japanese government-backed innovation agency

Sonire Therapeutics has been awarded a $13 million grant from Japan’s New Energy and Industrial Technology Development Organization (NEDO) to accelerate development of its...

Icarus Medical secures $7.2M Series A to accelerate growth and innovation

Icarus Medical has secured an oversubscribed $7.2 million Series A financing round to accelerate commercialization and development of its orthopedic bracing technologies. The Charlottesville-based medtech...

M&A

Archives

Latest articles

Load more

Popular categories

Funding1158Regulatory Approvals1027Innovation656Clinical Trials527Mergers & Acquisitions511GS Funding Tracker54